Pain Management

Changes coming to combat opioid addictions and overuse, as well as mitigate rising drug prices. 

Health systems employ Artifical Intelligence and integrated medication management to address diversion.

CVS vs Amazon, Naxolone, and more. 

CVS health care defended itself after the drugstore chain and Walgreens were added to a Florida lawsuit alleging that they failed to stop suspicious opioid prescriptions.

As federal and other regulations on opioid pain relievers are changing, NCPA presented a panel discussion on “Opioid Pain Management and Your Pharmacy” at its Annual Convention in Boston.

A new FDA plan will offer new education opportunities for a variety of healthcare workers.

The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.

The September Small Doses brings you the latest news that affects pharmacists.

Why pharmacists need to be paying attention to the Trinity II case and its consequences.

Small Doses is back, bringing you the pharmacy news you need in a way that works for you.

A Kentucky pharmacy owner was recently accused of making custom pain pills for pill mills.

Opioid shortages have hit hospitals all over the country.

Easy-to-swallow bits of news from the past month, tailored for the busy pharmacist.

What you need to know about the latest FDA approval.

In one recent example, a pharmacist tackled the robber-but was that the right move?

NACDS is welcoming a recent bill mandating e-prescribing.

What do pharmacies have to do with the recent Surgeon General Advisory? A lot, actually.

Pharmacists have a responsibility to help control opioid misuse, but how do you prove that you’re doing everything right?

Greater awareness of the dangers posed by prescription opioids is changing pharmacy practice.

An independent pharmacy opted to settle a wrongful death lawsuit involving an opioid prescription.

In an effort to combat opioids, the FDA is pushing blister packs-something pharmacy groups have been advocating for.

Pharmacy groups are praising new Medicare Part D opioid limits.

How a gel could prevent opioid abuse and get pharmacists more involved.